Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Annalisa Imovilli"'
Autor:
Fabio Efficace, Laura Cannella, Xavier Thomas, Meltem Kurt Yüksel, Silvia Maria Trisolini, Alberto Brini, Ernesta Audisio, Luca Maurillo, Roberto M. Lemoli, Annalisa Imovilli, Irina Panovska-Stavridis, Livio Pagano, Maria Ciccone, Nunzio Filardi, Nicola Stefano Fracchiolla, Daniele Vallisa, Monica Crugnola, Nicola Cascavilla, Matevz Skerget, Marco Vignetti, Frederic Baron, On Behalf of the Gimema and Eortc Leukemia and Quality of Life Groups
Publikováno v:
HemaSphere, Vol 7, p e90211c0 (2023)
Externí odkaz:
https://doaj.org/article/1c2b993187f2494ab0ad977e17937429
Autor:
Leonardo Potenza, Daniela Vallerini, Patrizia Barozzi, Giovanni Riva, Fabio Forghieri, Anne Beauvais, Remi Beau, Anna Candoni, Johan Maertens, Giulio Rossi, Monica Morselli, Eleonora Zanetti, Chiara Quadrelli, Mauro Codeluppi, Giovanni Guaraldi, Livio Pagano, Morena Caira, Cinzia Del Giovane, Monica Maccaferri, Alessandro Stefani, Uliano Morandi, Giovanni Tazzioli, Massimo Girardis, Mario Delia, Giorgina Specchia, Giuseppe Longo, Roberto Marasca, Franco Narni, Francesco Merli, Annalisa Imovilli, Giovanni Apolone, Agostinho Carvalho, Patrizia Comoli, Luigina Romani, Jean Paul Latgè, Mario Luppi
Publikováno v:
PLoS ONE, Vol 8, Iss 9, p e74326 (2013)
Several studies in mouse model of invasive aspergillosis (IA) and in healthy donors have shown that different Aspergillus antigens may stimulate different adaptive immune responses. However, the occurrence of Aspergillus-specific T cells have not yet
Externí odkaz:
https://doaj.org/article/e47bb1abb7c949d98af917432aeb935f
Autor:
Maria Chiara Finazzi, Alessia Civini, Chiara Pavoni, Anna Grassi, Maria Caterina Mico', Alessandra Algarotti, Marta Bellini, Francesca Patriarca, Paola Guglielmelli, Mario Luppi, Elisa Rumi, Nicola Polverelli, Giuseppe Messina, Stefania Bregante, Giuseppe Milone, Annalisa Imovilli, Benedetto Bruno, Maurizio Musso, Stella Santarone, Massimo Pini, Martina Pennisi, Orietta Spinelli, Francesca Bonifazi, Alessandro Rambaldi, Silvia Salmoiraghi
Publikováno v:
Blood. 140:10622-10623
Autor:
Claudio Cerchione, Antonella Padella, Anna Maria Ferrari, Andrea Ghelli Luserna di Rorà, Lorenzo Ledda, Enrica Imbrogno, Giorgia Simonetti, Monica Fumagalli, Maria Teresa Bochicchio, Maria Chiara Fontana, Roberta Napolitano, Annalisa Imovilli, Gerardo Musuraca, Martina Ghetti, Matteo Bocconcelli, Giovanni Martinelli, Chiara Liverani, Michela Rondoni, Matteo Paganelli, Seydou Sanogo, Valentina Robustelli
Doxorubicin (Dox) is one of the most commonly used anthracyclines for the treatment of solid and hematological tumors such as B−/T cell acute lymphoblastic leukemia (ALL). Dox compromises topoisomerase II enzyme functionality, thus inducing structu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dac608fe27973b94efdf26cebfd6780d
https://doi.org/10.21203/rs.3.rs-483365/v1
https://doi.org/10.21203/rs.3.rs-483365/v1
Autor:
Elisabetta Abruzzese, Giorgia Simonetti, Andrea Ghelli Luserna di Rorà, Fabio Giglio, Michela Rondoni, Cristina Papayannidis, Annalisa Imovilli, Giovanni Martinelli, Chiara Domizio, Daniele Calistri, Anna Maria Ferrari, Ilaria Iacobucci, Jesús María Hernández-Rivas
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
Recent genomic studies have identified a wide range of novel genetic alterations that have substantially increased our knowledge of the biology of B- and T-progenitor acute lymphoblastic leukaemia (B-ALL, T-ALL) and defined new subtypes with prognost
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05823db968c939b201db4935fcc76d16
http://hdl.handle.net/10261/262118
http://hdl.handle.net/10261/262118
Autor:
Fabio Stagno, Flavio Mignone, Erika Borlenghi, Elena Maino, Cristina Papayannidis, Simona Soverini, Manuela Stulle, Annalisa Imovilli, Claudia Basilico, Sabina Russo, Claudio Fozza, Chiara Sartor, Stefania Stella, Michele Cavo, Mario Annunziata, Roberta Minari, Federica Sorà, Michele Baccarani, Caterina De Benedittis, Luana Bavaro, Margherita Martelli, Francesco Albano, Massimiliano Bonifacio, Giovanni Martinelli, Elisabetta Abruzzese, Sara Galimberti
Publikováno v:
British journal of haematologyReferences. 193(2)
BCR-ABL1 kinase domain mutation testing in tyrosine kinase inhibitor (TKI)-resistant Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukaemia (ALL) patients is routinely performed by Sanger sequencing (SS). Recently, next-generation seque
Autor:
Damiano Angelini, Federico Gasparini, Andrea Zangrandi, Manuela Napoli, Caterina Barletta-Rodolfi, Enrico Ghidoni, Annalisa Imovilli, Alessandro Marti
Publikováno v:
The Clinical Neuropsychologist. 33:798-810
A case report of a 74-year-old male presenting with an atypical multimodal semantic impairment. The patient was diagnosed with Waldenström macroglobulinemia (WM) for which he received allogeneic bone marrow transplantation (BMT) due to disease progr
Autor:
Elisabetta Todisco, L. Santoro, Massimiliano Bonifacio, Mariarita Sciumè, Pasquale De Roberto, Sabina Chiaretti, Carmela Gurrieri, Monia Lunghi, Marzia Defina, Annalisa Imovilli, Robin Foà, Prassede Salutari, Barbara Scappini, Fabio Forghieri, Fabio Giglio, Nicola Stefano Fracchiolla, Michelina Dargenio, Maria Ilaria Del Principe, Chiara Sartor, Davide Lazzarotto, Elisa Buzzatti, Luca Baldini, Enrico Barozzi, Mario Annunziata, Patrizia Zappasodi, Cristina Papayannidis, Marco Cerrano, Antonio Curti, Antonella Vitale
Publikováno v:
Blood. 138:3408-3408
Blinatumomab (Blina) and inotuzumab (InO) have improved the outcome of relapsed/refractory B-lymphoblastic leukemia (R/R B-ALL). However, many patients (pts) relapse after these treatments and little is known on their outcomes after recurrence and re
Autor:
Elisabetta Abruzzese, Fausto Castagnetti, Barbara Sinigaglia, Annalisa Imovilli, Sara Galimberti, Gianantonio Rosti, Michele Baccarani, Gabriele Gugliotta, Claudia Baratè, Cecilia Monaldi, Monica Crugnola, Marzia Salvucci, Antonella Gozzini, Manuela Mancini, Mario Tiribelli, Elisa Dan, Simona Soverini, Gianni Binotto, Alessandra Iurlo, Elena Trabacchi, Michele Cavo, Francesco Albano, Sara De Santis, Massimiliano Bonifacio, Giovanni Martinelli, Patrizia Pregno, Elisabetta Calistri, Margherita Martelli
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:S236-S237
Context SETD2 is a tumor suppressor encoding a histone methyltransferase that trimethylates histone H3 at lysine 36 (H3K36Me3) and is involved in various cellular processes, including transcriptional regulation and repair of DNA damage. SETD2 loss of
Autor:
Mario Tiribelli, Massimiliano Bonifacio, Barbara Sinigaglia, Annalisa Imovilli, Simona Soverini, Giovanni Martinelli, Antonella Gozzini, Alessandra Iurlo, Gabriele Gugliotta, Maria Chiara Fontana, Elisa Dan, Michele Baccarani, Elisabetta Calistri, Elisabetta Abruzzese, Luana Bavaro, Margherita Martelli, Monica Crugnola, Gianantonio Rosti, Manuela Mancini, Marzia Salvucci, Sara Galimberti, Claudia Baratè, Fausto Castagnetti, Elena Trabacchi, Patrizia Pregno, Cecilia Monaldi, Michele Cavo, Francesco Albano, Sara De Santis, Nicola Orofino, Elena Tenti, Gianni Binotto
Publikováno v:
Blood. 132:1726-1726
The SETD2 protein is a histone methyltransferase that specifically catalyzes the trimethylation of Lysine 36 on histone H3 (H3K36me3). SETD2/H3K36me3 are implicated in transcript elongation and splicing, DNA repair, chromosome segregation. SETD2 gene